-
1
-
-
32644436929
-
B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure
-
Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006;47:742-748.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 742-748
-
-
Iwanaga, Y.1
Nishi, I.2
Furuichi, S.3
Noguchi, T.4
Sase, K.5
Kihara, Y.6
Goto, Y.7
Nonogi, H.8
-
2
-
-
1242295182
-
Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure
-
Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004;43:635-641.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 635-641
-
-
Logeart, D.1
Thabut, G.2
Jourdain, P.3
Chavelas, C.4
Beyne, P.5
Beauvais, F.6
Bouvier, E.7
Solal, A.C.8
-
3
-
-
30944450154
-
Incremental prognostic value of changes in B-type natriuretic peptide in heart failure
-
Latini R, Masson S, Wong M, Barlera S, Carretta E, Staszewsky L, Vago T, Maggioni AP, Anand IS, Tan LB, Tognoni G, Cohn JN. Incremental prognostic value of changes in B-type natriuretic peptide in heart failure. Am J Med 2006;119:70.e23-70.e30.
-
(2006)
Am J Med
, vol.119
, pp. 70.e23-70.e30
-
-
Latini, R.1
Masson, S.2
Wong, M.3
Barlera, S.4
Carretta, E.5
Staszewsky, L.6
Vago, T.7
Maggioni, A.P.8
Anand, I.S.9
Tan, L.B.10
Tognoni, G.11
Cohn, J.N.12
-
4
-
-
5644268954
-
N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients
-
Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-2174.
-
(2004)
Circulation
, vol.110
, pp. 2168-2174
-
-
Bettencourt, P.1
Azevedo, A.2
Pimenta, J.3
Frioes, F.4
Ferreira, S.5
Ferreira, A.6
-
5
-
-
34447536189
-
Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure
-
Bayes-Genis A, Pascual-Figal D, Fabregat J, Domingo M, Planas F, Casas T, Ordonez-Llanos J, Valdes M, Cinca J. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol 2007;120:338-343.
-
(2007)
Int J Cardiol
, vol.120
, pp. 338-343
-
-
Bayes-Genis, A.1
Pascual-Figal, D.2
Fabregat, J.3
Domingo, M.4
Planas, F.5
Casas, T.6
Ordonez-Llanos, J.7
Valdes, M.8
Cinca, J.9
-
6
-
-
79953253143
-
Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure
-
Michtalik HJ, Yeh HC, Campbell CY, Haq N, Park H, Clarke W, Brotman DJ. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure. Am J Cardiol 2011;107:1191-1195.
-
(2011)
Am J Cardiol
, vol.107
, pp. 1191-1195
-
-
Michtalik, H.J.1
Yeh, H.C.2
Campbell, C.Y.3
Haq, N.4
Park, H.5
Clarke, W.6
Brotman, D.J.7
-
7
-
-
59249083643
-
BNP-guided vs symptom-guided heart failure therapy: The Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial
-
Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 2009;301:383-392.
-
(2009)
JAMA
, vol.301
, pp. 383-392
-
-
Pfisterer, M.1
Buser, P.2
Rickli, H.3
Gutmann, M.4
Erne, P.5
Rickenbacher, P.6
Vuillomenet, A.7
Jeker, U.8
Dubach, P.9
Beer, H.10
Yoon, S.I.11
Suter, T.12
Osterhues, H.H.13
Schieber, M.M.14
Hilti, P.15
Schindler, R.16
Brunner-La Rocca, H.P.17
-
8
-
-
80055011831
-
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction
-
Januzzi JL Jr, Rehman SU, Mohammed AA, Bhardwaj A, Barajas L, Barajas J, Kim HN, Baggish AL, Weiner RB, Chen-Tournoux A, Marshall JE, Moore SA, Carlson WD, Lewis GD, Shin J, Sullivan D, Parks K,Wang TJ, Gregory SA, Uthamalingam S, Semigran MJ. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol 2011;58:1881-1889.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 1881-1889
-
-
Januzzi, J.L.1
Rehman, S.U.2
Mohammed, A.A.3
Bhardwaj, A.4
Barajas, L.5
Barajas, J.6
Kim, H.N.7
Baggish, A.L.8
Weiner, R.B.9
Chen-Tournoux, A.10
Marshall, J.E.11
Moore, S.A.12
Carlson, W.D.13
Lewis, G.D.14
Shin, J.15
Sullivan, D.16
Parks, K.17
Wang, T.J.18
Gregory, S.A.19
Uthamalingam, S.20
Semigran, M.J.21
more..
-
9
-
-
77951059915
-
B-type natriuretic peptide-guided heart failure therapy: A meta-analysis
-
Porapakkham P, Porapakkham P, Zimmet H, Billah B, Krum H. B-type natriuretic peptide-guided heart failure therapy: A meta-analysis. Arch Int Med 2010;170:507-514.
-
(2010)
Arch Int Med
, vol.170
, pp. 507-514
-
-
Porapakkham, P.1
Porapakkham, P.2
Zimmet, H.3
Billah, B.4
Krum, H.5
-
10
-
-
68849114272
-
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
-
Felker GM, Hasselblad V, Hernandez AF, O'Connor CM. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009;158:422-430.
-
(2009)
Am Heart J
, vol.158
, pp. 422-430
-
-
Felker, G.M.1
Hasselblad, V.2
Hernandez, A.F.3
O'Connor, C.M.4
-
11
-
-
78149498617
-
Post-discharge changes in NT-proBNP and quality of life after acute dyspnoea hospitalization as predictors of one-year outcomes
-
Shah KB, Kop WJ, Christenson RH, Diercks DB, Kuo D, Henderson S, Hanson K, deFilippi CR. Post-discharge changes in NT-proBNP and quality of life after acute dyspnoea hospitalization as predictors of one-year outcomes. Clin Biochem 2010;43:1405-1410.
-
(2010)
Clin Biochem
, vol.43
, pp. 1405-1410
-
-
Shah, K.B.1
Kop, W.J.2
Christenson, R.H.3
Diercks, D.B.4
Kuo, D.5
Henderson, S.6
Hanson, K.7
DeFilippi, C.R.8
-
12
-
-
84861553275
-
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: Analysis from the EVEREST trial
-
Gheorghiade M, Pang PS, Ambrosy AP, Lan G, Schmidt P, Filippatos G, Konstam M, Swedberg K, Cook T, Traver B, Maggioni A, Burnett J, Grinfeld L, Udelson J, Zannad F. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev 2012;17:485-509.
-
(2012)
Heart Fail Rev
, vol.17
, pp. 485-509
-
-
Gheorghiade, M.1
Pang, P.S.2
Ambrosy, A.P.3
Lan, G.4
Schmidt, P.5
Filippatos, G.6
Konstam, M.7
Swedberg, K.8
Cook, T.9
Traver, B.10
Maggioni, A.11
Burnett, J.12
Grinfeld, L.13
Udelson, J.14
Zannad, F.15
-
14
-
-
84875176312
-
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: The ASTRONAUT randomized trial
-
Gheorghiade M, Bohm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA 2013;309:1125-1135.
-
(2013)
JAMA
, vol.309
, pp. 1125-1135
-
-
Gheorghiade, M.1
Bohm, M.2
Greene, S.J.3
Fonarow, G.C.4
Lewis, E.F.5
Zannad, F.6
Solomon, S.D.7
Baschiera, F.8
Botha, J.9
Hua, T.A.10
Gimpelewicz, C.R.11
Jaumont, X.12
Lesogor, A.13
Maggioni, A.P.14
-
15
-
-
78650344825
-
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)
-
Gheorghiade M, Albaghdadi M, Zannad F, Fonarow GC, Bohm M, Gimpelewicz C, Botha J, Moores S, Lewis EF, Rattunde H, Maggioni A. Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT). Eur J Heart Fail 2011;13:100-106.
-
(2011)
Eur J Heart Fail
, vol.13
, pp. 100-106
-
-
Gheorghiade, M.1
Albaghdadi, M.2
Zannad, F.3
Fonarow, G.C.4
Bohm, M.5
Gimpelewicz, C.6
Botha, J.7
Moores, S.8
Lewis, E.F.9
Rattunde, H.10
Maggioni, A.11
-
16
-
-
84890544617
-
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: Insights from the ASTRONAUT trial
-
Maggioni AP, Greene SJ, Fonarow GC, Bohm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M. Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial. Eur Heart J 2013;34:3117-3127.
-
(2013)
Eur Heart J
, vol.34
, pp. 3117-3127
-
-
Maggioni, A.P.1
Greene, S.J.2
Fonarow, G.C.3
Bohm, M.4
Zannad, F.5
Solomon, S.D.6
Lewis, E.F.7
Baschiera, F.8
Hua, T.A.9
Gimpelewicz, C.R.10
Lesogor, A.11
Gheorghiade, M.12
-
17
-
-
84888317394
-
Natriuretic peptides as biomarkers in heart failure
-
Januzzi JL Jr. Natriuretic peptides as biomarkers in heart failure. J Investig Med 2013;61:950-955.
-
(2013)
J Investig Med
, vol.61
, pp. 950-955
-
-
Januzzi, J.L.1
-
18
-
-
50949104678
-
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
-
Masson S, Latini R, Anand IS, Barlera S, Angelici L, Vago T, Tognoni G, Cohn JN, Val-He FTI. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial). J Am Coll Cardiol 2008;52:997-1003.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 997-1003
-
-
Masson, S.1
Latini, R.2
Anand, I.S.3
Barlera, S.4
Angelici, L.5
Vago, T.6
Tognoni, G.7
Cohn, J.N.8
Val-He, F.T.I.9
-
19
-
-
84856384714
-
Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: Data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims
-
Kociol RD, Horton JR, Fonarow GC, Reyes EM, Shaw LK, O'Connor CM, Felker GM, Hernandez AF. Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail 2011;4:628-636.
-
(2011)
Circ Heart Fail
, vol.4
, pp. 628-636
-
-
Kociol, R.D.1
Horton, J.R.2
Fonarow, G.C.3
Reyes, E.M.4
Shaw, L.K.5
O'Connor, C.M.6
Felker, G.M.7
Hernandez, A.F.8
-
20
-
-
77950295232
-
Critical elements of clinical follow-up after hospital discharge for heart failure: Insights from the EVEREST trial
-
Dunlay SM, Gheorghiade M, Reid KJ, Allen LA, Chan PS, Hauptman PJ, Zannad F, Maggioni AP, Swedberg K, Konstam MA, Spertus JA. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail 2010;12:367-374.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 367-374
-
-
Dunlay, S.M.1
Gheorghiade, M.2
Reid, K.J.3
Allen, L.A.4
Chan, P.S.5
Hauptman, P.J.6
Zannad, F.7
Maggioni, A.P.8
Swedberg, K.9
Konstam, M.A.10
Spertus, J.A.11
-
21
-
-
80053209207
-
Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life
-
Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes 2011;4:389-398.
-
(2011)
Circ Cardiovasc Qual Outcomes
, vol.4
, pp. 389-398
-
-
Allen, L.A.1
Gheorghiade, M.2
Reid, K.J.3
Dunlay, S.M.4
Chan, P.S.5
Hauptman, P.J.6
Zannad, F.7
Konstam, M.A.8
Spertus, J.A.9
-
23
-
-
84908060979
-
Rationale and design of the GUIDE-IT Study: Guiding evidence based therapy using biomarker intensified treatment in heart failure
-
Felker GM, Ahmad T, Anstrom KJ, Adams KF, Cooper LS, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Leifer ES, Mark DB, Desvigne-Nickens P, Paynter G, Pina IL, Whellan DJ, O'Connor CM. Rationale and design of the GUIDE-IT Study: guiding evidence based therapy using biomarker intensified treatment in heart failure. J Am Coll Cardiol HF 2014;2:457-465.
-
(2014)
J Am Coll Cardiol HF
, vol.2
, pp. 457-465
-
-
Felker, G.M.1
Ahmad, T.2
Anstrom, K.J.3
Adams, K.F.4
Cooper, L.S.5
Ezekowitz, J.A.6
Fiuzat, M.7
Houston-Miller, N.8
Januzzi, J.L.9
Leifer, E.S.10
Mark, D.B.11
Desvigne-Nickens, P.12
Paynter, G.13
Pina, I.L.14
Whellan, D.J.15
O'Connor, C.M.16
-
24
-
-
33751059230
-
Congestion in acute heart failure syndromes: An essential target of evaluation and treatment
-
Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med 2006;119:S3-S10.
-
(2006)
Am J Med
, vol.119
, pp. S3-S10
-
-
Gheorghiade, M.1
Filippatos, G.2
De Luca, L.3
Burnett, J.4
-
25
-
-
84875165977
-
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: Findings from the EVEREST trial
-
Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, Maggioni AP, Cook T, Swedberg K, Burnett JC Jr, Grinfeld L, Udelson JE, Zannad F, Gheorghiade M. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 2013;34:835-843.
-
(2013)
Eur Heart J
, vol.34
, pp. 835-843
-
-
Ambrosy, A.P.1
Pang, P.S.2
Khan, S.3
Konstam, M.A.4
Fonarow, G.C.5
Traver, B.6
Maggioni, A.P.7
Cook, T.8
Swedberg, K.9
Burnett, J.C.10
Grinfeld, L.11
Udelson, J.E.12
Zannad, F.13
Gheorghiade, M.14
-
26
-
-
77954951329
-
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival
-
Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010;122:265-272.
-
(2010)
Circulation
, vol.122
, pp. 265-272
-
-
Testani, J.M.1
Chen, J.2
McCauley, B.D.3
Kimmel, S.E.4
Shannon, R.P.5
-
27
-
-
84890094446
-
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: Insights from the EVEREST trial
-
Greene SJ, Gheorghiade M, Vaduganathan M, Ambrosy AP, Mentz RJ, Subacius H, Maggioni AP, Nodari S, Konstam MA, Butler J, Filippatos G. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 2013;15:1401-1411.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1401-1411
-
-
Greene, S.J.1
Gheorghiade, M.2
Vaduganathan, M.3
Ambrosy, A.P.4
Mentz, R.J.5
Subacius, H.6
Maggioni, A.P.7
Nodari, S.8
Konstam, M.A.9
Butler, J.10
Filippatos, G.11
-
28
-
-
33845293260
-
Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study
-
Morello A, Lloyd-Jones DM, Chae CU, van Kimmenade RR, Chen AC, Baggish AL, O'Donoghue M, Lee-Lewandrowski E, Januzzi JL Jr. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 2007;153:90-97.
-
(2007)
Am Heart J
, vol.153
, pp. 90-97
-
-
Morello, A.1
Lloyd-Jones, D.M.2
Chae, C.U.3
Van Kimmenade, R.R.4
Chen, A.C.5
Baggish, A.L.6
O'Donoghue, M.7
Lee-Lewandrowski, E.8
Januzzi, J.L.9
-
29
-
-
84878623090
-
Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: Results from the BACH study (Biomarkers in ACute Heart Failure)
-
Richards M, Di Somma S, Mueller C, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Clopton P, Filippatos GS, Anand I, Ng L, Daniels LB, Neath SX, Shah K, Christenson R, Hartmann O, Anker SD, Maisel A. Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH study (Biomarkers in ACute Heart Failure). J Am Coll Cardiol HF 2013;1:192-199.
-
(2013)
J Am Coll Cardiol HF
, vol.1
, pp. 192-199
-
-
Richards, M.1
Di Somma, S.2
Mueller, C.3
Nowak, R.4
Peacock, W.F.5
Ponikowski, P.6
Mockel, M.7
Hogan, C.8
Wu, A.H.9
Clopton, P.10
Filippatos, G.S.11
Anand, I.12
Ng, L.13
Daniels, L.B.14
Neath, S.X.15
Shah, K.16
Christenson, R.17
Hartmann, O.18
Anker, S.D.19
Maisel, A.20
more..
-
30
-
-
84870292204
-
Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial
-
Mentz RJ, Chung MJ, Gheorghiade M, Pang PS, Kwasny MJ, Ambrosy AP, Vaduganathan M, O'Connor CM, Swedberg K, Zannad F, Konstam MA and Maggioni AP. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial. Am Heart J 2012;164:884-892.e2.
-
(2012)
Am Heart J
, vol.164
, pp. 884-892.e2
-
-
Mentz, R.J.1
Chung, M.J.2
Gheorghiade, M.3
Pang, P.S.4
Kwasny, M.J.5
Ambrosy, A.P.6
Vaduganathan, M.7
O'Connor, C.M.8
Swedberg, K.9
Zannad, F.10
Konstam, M.A.11
Maggioni, A.P.12
-
31
-
-
33745602752
-
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: Determinants and prognostic value of (NT-)ANP and (NT-pro)BNP
-
Rienstra M, Van Gelder IC, Van den Berg MP, Boomsma F, Van Veldhuisen DJ. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP. Europace 2006;8:482-487.
-
(2006)
Europace
, vol.8
, pp. 482-487
-
-
Rienstra, M.1
Van Gelder, I.C.2
Van Den Berg, M.P.3
Boomsma, F.4
Van Veldhuisen, D.J.5
-
32
-
-
33746595717
-
Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: The Valsartan Heart Failure (Val-HeFT) data
-
Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 2006;52:1528-38.
-
(2006)
Clin Chem
, vol.52
, pp. 1528-1538
-
-
Masson, S.1
Latini, R.2
Anand, I.S.3
Vago, T.4
Angelici, L.5
Barlera, S.6
Missov, E.D.7
Clerico, A.8
Tognoni, G.9
Cohn, J.N.10
-
33
-
-
84873110684
-
Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management
-
Januzzi JL, Troughton R. Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management. Circulation 2013;127:500-507.
-
(2013)
Circulation
, vol.127
, pp. 500-507
-
-
Januzzi, J.L.1
Troughton, R.2
|